2235.HK
MICROTECH MED-B
HK$7.34
-3.67%
2026-05-29
About MICROTECH MED-B
MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software. It also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials business. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
Key Fundamentals
P/E Ratio
61.17
Forward P/E
15.65
EPS (TTM)
HK$0.12
ROE
2.0%
Revenue Growth (YoY)
113.0%
Profit Margin
6.1%
Debt/Equity
3.22
Price/Book
1.32
Beta
0.51
Market Cap
HK$3.01B
Avg Volume (10D)
119K
Recent Breakout Signals
No recent breakout signals detected for 2235.HK.
Recent Price Range (60 Days)
60D High
HK$8.28
60D Low
HK$6.24
Avg Volume
139K
Latest Close
HK$7.34
Get breakout alerts for 2235.HK
Sign up for Breakout Scanner to receive daily notifications when 2235.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
MICROTECH MED-B (2235.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2235.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2235.HK operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.